Unknown Gem with Brutal Upside Potential.
Another 2 NDA filings and 2-3 Partnerships coming this Year ..Only 20 M on the float ..
IGXT has the Potential to hit $10++ within 2 Year ! GLTA
Market Cap : $28 M
Cash: $3 M
Burn-Rate : $1.2 M a year
Shares Out : 51 M ( 30 M shares are held by Investors )
IGXT´s Monster Pipeline :
Product ......Application......... Status of Development
INT0004/2006 Antidepressant -- US launch in 4Q 2012
INT0008/2007 Migraine -- PDUFA Date on Feb 3 2014
INT0007/2006 Erectile Dysfunction -- NDA filing later in 2013
INT0001/2004 CHF (Coronary Heart Failure), Hypertension -- ANDA filing later in 2013
INT0027/2011 Undisclosed Partnered with Par Pharma -- ANDA filing later in 2013
INT0020/2010 Insomnia -- in Pivotal Study
INT0024/2010 Idiopathic pulmonary fibrosis -- in Pivotal Study
INT0028/2011 Cancer pain (cannabinoid) --in Pivotal Study
INT0030/2011 Animal health -- in Pivotal Study
INT0031/2012 Benign prostatic hyperplasia --in Pivotal Study
You said that already SPAMMER!
Since you are obviously exercising your self interest repeatedly, at the cost of our time..
I think you owe each of us at least a few bucks each time we read it.